BTK Inhibitors for Follicular Lymphoma

(MedPage Today) -- Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a malignancy where the first-generation drug ibrutinib (Imbruvica) failed.
"When the first BTK inhibitor...